Skip to content

Bronchial Allergen Provocation Tests in Asthmatics in Guangzhou

Bronchial Provocation Tests With House Dust Mite in Allergic Asthma in Guangzhou

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02504528
Enrollment
30
Registered
2015-07-22
Start date
2015-07-01
Completion date
2018-02-01
Last updated
2018-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic Asthma

Keywords

asthma, allergy, bronchial hyperresponsiveness, provocation

Brief summary

The purpose of this study is to establish the methodology of bronchial provocation tests with house dust mites in China, and to evaluate its safety and effects on upper and lower airways inflammation.

Detailed description

After screening,each participant undergo baseline lung function test,airway inflammation evaluation (blood and sputum eosinophils count,interleukin-13 (IL-13),FeNO)and airway responsiveness tests(methacholine bronchial provocation,nasal histamine provocation). On the second day,the participant undergo bronchial house dust mites challenge tests. On the third day,the participant undergo the lung function test,airway inflammation evaluation (blood and sputum eosinophils count,IL-13,FeNO)and airway responsiveness tests(methacholine bronchial provocation,nasal histamine provocation).

Interventions

OTHERhouse dust mites

house dust mites(two-fold increasing concentration of house dust mite (HDM) extract, dilutions prepared starting from 1:8, 1:16, 1:32, 1:64, 1:128, 1: 256, 1:512, 1:1024,……)

Sponsors

Firestone Institute for Respiratory Health
CollaboratorOTHER
Guangzhou Institute of Respiratory Disease
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Clinical diagnosis of asthma; * Sensitive to house dust mite; * Stable for more than 4 weeks with FEV1≥70%pred

Exclusion criteria

* exacerbation within 3 months; * upper airway infections within 6 weeks; * concomitant of hypertension or heart diseases; * pregnancy

Design outcomes

Primary

MeasureTime frame
percentages of the participants that tested positive to house dust mites bronchial provocation30 minutes after house dust mites bronchial provocation

Secondary

MeasureTime frameDescription
Changes of the percentages of eosinophils in sputum, nasal lavage and fractional exhaled nitric oxide (FeNO) from baseline30mins, 7 and 24 hours after bronchial challenge
Changes of provocative concentration induced a 20% decrease in forced expiratory volume at one second (FEV1) to methacholine before and after house dust mites bronchial provocation24 hours after house dust mites bronchial challenge
percentages of the participants that tested positive to house dust mites bronchial provocation measured by impulse oscillometry10 minutes after house dust mites bronchial provocation
Changes of provocative concentration induced a 60% increase in nasal airway resistance to histamine before and after house dust mites bronchial provocation24 hours after house dust mites bronchial challengeBy Comparison with methacholine provocation test

Other

MeasureTime frameDescription
correlate of IL-4,IL-13,periostin with provocative concentration induced a 20% decrease in FEV1 to house dust mite in asthmatic30 mins and 24 hours after house dust mites bronchial challengeBy Comparison with methacholine provocation test
Incidence and Severity of Adverse Events During The House Dust Mite Bronchial Provocation Test30 minutes, 7 hours and 24 hours after house dust mites bronchial provocationBy Comparison with methacholine provocation test at 30 min and 24 hours after challenge test.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026